Mer­ck KGaA is spend­ing $85 mil­lion to tap glob­al com­mer­cial­iza­tion rights to pim­i­co­tinib, a can­di­date for non-ma­lig­nant tu­mors that it li­censed from Chi­na’s ...

Unsurprisingly, the ingredient list is also where the most notable differences lie. “Crème de la Mer’s formula is centered around its ‘Miracle Broth,’” Shokeen Khalsa said. ”[This] is a fermented mix ...